Free Trial

BriaCell Therapeutics (BCTX) Earnings Date, Estimates & Call Transcripts

BriaCell Therapeutics logo
$0.56 -0.02 (-4.12%)
(As of 12/20/2024 05:51 PM ET)

BriaCell Therapeutics Latest Earnings Summary

Actual EPS
(Dec. 16)
-$0.22 Missed By -$0.14
Consensus EPS
(Dec. 16)
-$0.08

BriaCell Therapeutics issued Q1 2025 earnings on December 16, 2024, reporting an EPS of -$0.22, which missed the consensus estimate of -$0.08 by $0.14. With a trailing EPS of -$0.89, BriaCell Therapeutics' earnings are expected to grow next year, from ($1.01) to ($0.84) per share.

Get BriaCell Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BriaCell Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BCTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BCTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BriaCell Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20241-$0.55-$0.55-$0.55
Q4 20241-$0.52-$0.52-$0.52
20242-$1.07-$1.07-$1.07
Q1 20251-$0.08-$0.08-$0.08
Q2 20251-$0.27-$0.27-$0.27
Q3 20251-$0.30-$0.30-$0.30
Q4 20251-$0.33-$0.33-$0.33
FY 20254($0.98)($0.98)($0.98)

BriaCell Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
12/16/2024Q1 2025-$0.08-$0.22 -$0.14-$0.22--
10/28/2024Q4 2024-$0.52-$0.07+$0.45-$0.07--
6/14/2024--$0.55$0.11+$0.66$0.11--
3/18/2024Q2 2024-$0.20-$0.71 -$0.51-$0.71--
12/14/2023Q4 2023-$0.18-$0.50 -$0.32-$0.50--
10/25/2023Q4 2023-$0.40-$0.15+$0.25-$0.15--
6/14/2023Q3 2023-$0.36-$0.32+$0.04-$0.32--
3/15/2023Q2 2023-$0.37-$0.77 -$0.40-$0.77--

BriaCell Therapeutics Earnings - Frequently Asked Questions

BriaCell Therapeutics (NASDAQ:BCTX) last announced its quarterly earning data on Monday, December 16, 2024. Learn more on BCTX's earnings history.

In the previous quarter, BriaCell Therapeutics (NASDAQ:BCTX) missed the analysts' consensus estimate of ($0.08) by $0.14 with a reported earnings per share (EPS) of ($0.22). Learn more on analysts' earnings estimate vs. BCTX's actual earnings.

BriaCell Therapeutics (NASDAQ:BCTX) has a recorded net income of -$4.79 million. BCTX has generated -$0.89 earnings per share over the last four quarters.

BriaCell Therapeutics's earnings are expected to grow from ($1.01) per share to ($0.84) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BCTX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners